International Journal of Cancer Management

Published by: Kowsar

Treatment Outcomes and Prognostic Factors in Adult Astrocytoma: In North East of Iran

Kazem Anvari 1 , Mehdi Seilanian Toussi 1 , * , Soodabeh Shahidsales 1 , Farhad Motlagh 2 , Mohammad Reza Ehsaee 3 and Farzaneh Afshari 4
Authors Information
1 Cancer Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, IR Iran
2 Department of Neurosurgery, Aria & Farabi Hospitals, Faculty of Medicine, Mashhad Branch, Islamic Azad University, Mashhad, IR Iran
3 Department of Neurosurgery, Shahid Kamiab Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, IR Iran
4 Department of Radiation Oncology, Omid Hospital, Mashhad University of Medical Sciences, Mashhad, IR Iran
Article information
  • Iranian Journal of Cancer Prevention: August 2016, 9 (4); e4099
  • Published Online: March 26, 2016
  • Article Type: Research Article
  • Received: September 21, 2015
  • Accepted: November 7, 2015
  • DOI: 10.17795/ijcp-4099

How to Cite: Anvari K, Seilanian Toussi M, Shahidsales S, Motlagh F, Reza Ehsaee M, et al. Treatment Outcomes and Prognostic Factors in Adult Astrocytoma: In North East of Iran, Int J Cancer Manag. 2016 ; 9(4):e4099. doi: 10.17795/ijcp-4099.

Copyright © 2016, Iranian Journal of Cancer Prevention. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Kleihues P, Burger PC, Scheithauer BW. The new WHO classification of brain tumours. Brain Pathol. 1993; 3(3) : 255 -68 [DOI]
  • 2. Heath A. Principles and practice of radiation oncology. 2008;
  • 3. CBTRUS Statistical Report . Primary brain and central nervous system tumors diagnosed in the united states in 2004-2007. 2012;
  • 4. Seilanian Toussi M, Anvari K. Treatment outcomes of astrocytoma. 2004; 47 : 355 -60
  • 5. Daniels TB, Brown PD, Felten SJ, Wu W, Buckner JC, Arusell RM, et al. Validation of EORTC prognostic factors for adults with low-grade glioma: a report using intergroup 86-72-51. Int J Radiat Oncol Biol Phys. 2011; 81(1) : 218 -24 [DOI][PubMed]
  • 6. Waqar M, Hanif S, Brodbelt AR, Rathi N, Das K, Zakaria R, et al. Prognostic Factors in Lobar World Health Organization Grade II Astrocytomas. World Neurosurg. 2015; 84(1) : 154 -62 [DOI][PubMed]
  • 7. Shaw EG, Wisoff JH. Prospective clinical trials of intracranial low-grade glioma in adults and children. Neuro Oncol. 2003; 5(3) : 153 -60 [DOI][PubMed]
  • 8. Kilic T, Ozduman K, Elmaci I, Sav A, Necmettin Pamir M. Effect of surgery on tumor progression and malignant degeneration in hemispheric diffuse low-grade astrocytomas. J Clin Neurosci. 2002; 9(5) : 549 -52 [PubMed]
  • 9. McGirt MJ, Chaichana KL, Attenello FJ, Weingart JD, Than K, Burger PC, et al. Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas. Neurosurgery. 2008; 63(4) : 700 -7 [DOI][PubMed]
  • 10. Pignatti F, van den Bent M, Curran D, Debruyne C, Sylvester R, Therasse P, et al. Prognostic factors for survival in adult patients with cerebral low-grade glioma. J Clin Oncol. 2002; 20(8) : 2076 -84 [PubMed]
  • 11. Berger MS, Deliganis AV, Dobbins J, Keles GE. The effect of extent of resection on recurrence in patients with low grade cerebral hemisphere gliomas. Cancer. 1994; 74(6) : 1784 -91 [PubMed]
  • 12. Durmaz R, Vural M, Isildi E, Cosan E, Ozkara E, Bal C, et al. Efficacy of prognostic factors on survival in patients with low grade glioma. Turk Neurosurg. 2008; 18(4) : 336 -44 [PubMed]
  • 13. Leighton C, Fisher B, Bauman G, Depiero S, Stitt L, MacDonald D, et al. Supratentorial low-grade glioma in adults: an analysis of prognostic factors and timing of radiation. J Clin Oncol. 1997; 15(4) : 1294 -301 [PubMed]
  • 14. Catalan-Uribarrena G, Bilbao-Barandica G, Pomposo-Gaztelu I, Undabeitia-Huertas J, Ruiz de Gopegui-Ruiz E, Galbarriatu-Gutierrez L, et al. Prognostic factors and survival in a prospective cohort of patients with high-grade glioma treated with carmustine wafers or temozolomide on an intention-to-treat basis. Acta Neurochir (Wien). 2012; 154(2) : 211 -22 [DOI][PubMed]
  • 15. Laws ER, Parney IF, Huang W, Anderson F, Morris AM, Asher A, et al. Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. J Neurosurg. 2003; 99(3) : 467 -73 [DOI][PubMed]
  • 16. Wurschmidt F, Bunemann H, Heilmann HP. Prognostic factors in high-grade malignant glioma. A multivariate analysis of 76 cases with postoperative radiotherapy. Strahlenther Onkol. 1995; 171(6) : 315 -21 [PubMed]
  • 17. McCrea HJ, Bander ED, Venn RA, Reiner AS, Iorgulescu JB, Puchi LA, et al. Sex, Age, Anatomic Location, and Extent of Resection Influence Outcomes in Children With High-grade Glioma. Neurosurgery. 2015; 77(3) : 443 -52 [DOI][PubMed]
  • 18. Simpson JR, Horton J, Scott C, Curran WJ, Rubin P, Fischbach J, et al. Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: Results of three consecutive radiation therapy oncology group (rtog) clinical trials. Int J Radiat Oncol Biol Phys. 1993; 26(2) : 239 -44 [DOI]
  • 19. Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F, et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg. 2001; 95(2) : 190 -8 [DOI]
  • 20. Buckner JC. Factors influencing survival in high-grade gliomas. Semin Oncol. 2003; 30(6 Suppl 19) : 10 -4 [PubMed]
  • 21. Barker F2, Chang SM, Gutin PH, Malec MK, McDermott MW, Prados MD, et al. Survival and functional status after resection of recurrent glioblastoma multiforme. Neurosurgery. 1998; 42(4) : 709 -20 [PubMed]
  • 22. Wu W, Lamborn KR, Buckner JC, Novotny PJ, Chang SM, O'Fallon JR, et al. Joint NCCTG and NABTC prognostic factors analysis for high-grade recurrent glioma. Neuro Oncol. 2010; 12(2) : 164 -72 [DOI][PubMed]
  • 23. Stewart LA. Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet. 2002; 359(9311) : 1011 -8 [PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments